Biology of post-traumatic stress disorder in childhood and adolescence.
Diverse patterns of cortisol secretion with consistently high circulating catecholamines have been reported in post-traumatic stress disorder (PTSD), an anxiety state that develops after exposure to traumatic life events. Indeed, peripheral cortisol levels have been reported to be low or normal in the majority of adult chronic PTSD studies, whereas, in most paediatric studies, high cortisol values have been documented. Longitudinal studies on PTSD biology, including the transition from childhood to adulthood, may shed light on these discrepancies. In children, elevated evening salivary cortisol in the aftermath of the trauma was predictive of PTSD development 6 months later, whereas plasma interleukin-6 correlated positively with evening cortisol and was equally predictive of later PTSD. Longitudinal assessment of PTSD children 1 and 6 months later revealed progressive normalisation of cortisol levels, whereas noradrenaline concentrations became gradually higher. We hypothesise that, in adults with chronic PTSD, low cortisol levels, together with high catecholamines, may reflect a late event in the natural history of the disorder, months or years after the trauma. The progressive divergence of cortisol and noradrenaline concentrations over time may be responsible for PTSD maintenance in children and explain the differences between the child and adult PTSD endophenotypes. In adults studied immediately after the trauma, and by contrast to children, low cortisol levels are predictive of later PTSD development. Our hypothesis that low cortisol levels may reflect a previous trauma, earlier in development, is supported by the well established observation that prior trauma is a risk factor for a new PTSD diagnosis. The developmental stage of an individual in relation to previous exposure to trauma and PTSD vulnerability are crucial variables that may determine clinical and biological PTSD phenotypes and explain the discrepancies between adults and children in reported cortisol levels.
Pervanidou
P
P
Developmental-Behavioral Pediatrics Unit, First Department of Pediatrics, Athens University Medical School, Aghia Sophia Children's Hospital, Athens, Greece. ppervanid@med.uoa.gr
D000293:Adolescent; D000328:Adult; D002648:Child; D002940:Circadian Rhythm / Q000502:physiology; D018450:Disease Progression; D005260:Female; D047109:Fetal Development / Q000502:physiology; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007030:Hypothalamo-Hypophyseal System / Q000502:physiology; D015850:Interleukin-6 / Q000502:physiology; D008431:Maternal-Fetal Exchange / Q000502:physiology; D009638:Norepinephrine / Q000502:physiology; D010913:Pituitary-Adrenal System / Q000502:physiology; D011247:Pregnancy; D013313:Stress Disorders, Post-Traumatic / Q000097:blood* / Q000209:etiology / Q000235:genetics / Q000503:physiopathology*; D013315:Stress, Psychological / Q000097:blood / Q000235:genetics / Q000503:physiopathology; D035862:Vulnerable Populations; D014947:Wounds and Injuries / Q000150:complications / Q000235:genetics
D015850:Interleukin-6; D006854:Hydrocortisone; D009638:Norepinephrine